Spinal epidural abscess (SEA) is a suppurative infection of the epidural space — a high-risk, low-prevalence infectious disease emergency with up to 90% of patients misdiagnosed on their first ED visit. [1] The classic triad of back pain, fever, and neurologic deficit is present in fewer than 10–20% of cases at diagnosis. [2-3] Overall mortality is approximately 6–13% within 90 days. [2]
The following algorithm from the 2026 NEJM review outlines when to pursue urgent MRI in patients with suspected SEA:
1. History
- Key HPI questions: Characterize pain location (back vs. neck), onset, severity, and progression. Ask about radicular symptoms (shooting pain, numbness, paresthesias) and any new weakness, gait difficulty, or bowel/bladder changes [2][4]
- Symptom progression follows a classic 4-phase pattern: [2]
- Phase 1: Localized back/neck pain (>80% of patients)
- Phase 2: Radicular pain
- Phase 3: Motor weakness, sensory deficit, sphincter impairment (present at diagnosis in 20–47%)
- Phase 4: Paralysis (3–9% at diagnosis)
- Timing: One-third of patients have symptoms >2 weeks before diagnosis; neurologic symptoms typically present <1 week before diagnosis [2]
- Important negatives: Absence of acute back pain has a negative likelihood ratio of 0.19 for SEA in S. aureus bacteremia patients. However, the absence of risk factors cannot be used to exclude SEA [1][4]
2. Alarm Features
- New or progressive neurologic deficits — extremity weakness/numbness, bowel/bladder dysfunction, saddle anesthesia, gait instability [2]
- Rapidly progressive symptoms — neurologic deterioration can accelerate once it begins [2][5]
- Sepsis or hemodynamic instability (present in 25–35%) [2]
- Fever with severe, localized spinal tenderness in a patient with risk factors [6]
- Saddle anesthesia has the highest positive likelihood ratio (22.6) for ruling in SEA among S. aureus bacteremia patients [4]
3. Medications
- Empiric therapy: Vancomycin + ceftriaxone is an appropriate first-line regimen [2]
- Upgrade to cefepime (replacing ceftriaxone) in patients with IVDU, surgical-site infection, sepsis, or substantial neurologic deficits [2]
- Withhold antibiotics until cultures are obtained in neurologically intact, non-septic patients without cord compression — to maximize culture yield [2]
- Do not delay antibiotics in patients with sepsis, neurologic deficits, or hemodynamic instability — obtain blood cultures and start empiric therapy immediately [2][7]
- Duration: Typically 6–8 weeks of parenteral therapy, individualized to clinical response; oral step-down with highly bioavailable agents may be considered in selected patients with adequate response [2]
- Antifungals (voriconazole, amphotericin B) should be added if fungal etiology is suspected [7]
4. Diet
- No specific dietary triggers or recommendations unique to SEA
- Adequate nutrition and glycemic control are important, particularly in diabetic patients, to optimize infection management and wound healing
- Ensure adequate hydration, especially during prolonged IV antibiotic therapy
5. Review of Systems
- Neurologic: Weakness, numbness, paresthesias, gait changes, bowel/bladder dysfunction, saddle numbness [2][4]
- Constitutional: Fever, chills, night sweats, malaise, weight loss [2]
- Musculoskeletal: Localized spinal tenderness, radicular pain [2]
- Infectious sources: Skin/soft tissue infections, urinary symptoms, dental infections, recent procedures, endocarditis symptoms (new murmur, embolic phenomena) [8-9]
- Meningeal symptoms: Headache, neck stiffness — meningitis may accompany SEA if dural tear is present [2]
6. Collateral History and Family History
- Injection drug use history — often underreported; collateral from family/friends is critical (LR+ 13.7 for SEA) [6]
- Recent spinal procedures — epidural injections, surgery, lumbar puncture [2][10]
- Indwelling vascular catheters (LR+ 15.7) [6]
- Recent hospitalizations, infections, or bacteremia [9]
- Family history is generally not a major contributor, though immunodeficiency syndromes may be relevant
- Social context: housing instability, alcohol use disorder, HIV status [2][8]
7. Risk Factors
- Injection drug use — strongest independent risk factor in case-control data [2]
- Diabetes mellitus — most commonly reported comorbidity; also predicts failure of medical management [2][11]
- Immunocompromise — HIV, chronic steroid use, transplant, active cancer [2][8]
- Bacteremia / concurrent infection — skin infections, UTI, endocarditis, psoas abscess [1][9]
- Spinal instrumentation or recent spinal procedures [2][10]
- Alcohol abuse and obesity — independent risk factors [2]
- Renal failure / dialysis [2][8]
- Demographics: Predominantly male, age 50–65 years; median age ~55–63 years [2-3][12]
- Absence of risk factors does not exclude SEA — 22.7% of patients in one series had no identifiable risk factors [1][13]
8. Differential Diagnosis
- Vertebral osteomyelitis / discitis — often coexists with SEA; may be the primary process [8-9]
- Spinal subdural abscess — distinguished from SEA on MRI by preservation of the epidural space [2]
- Intramedullary spinal cord abscess — ring-enhancing cord lesion on contrast MRI [2]
- Spinal epidural hematoma — especially in anticoagulated patients; acute onset
- Spinal cord tumor / metastatic epidural compression — progressive neurologic deficits without infectious signs [8]
- Cauda equina syndrome (disc herniation) — bowel/bladder dysfunction, saddle anesthesia without fever
- Transverse myelitis — inflammatory, typically without fever or elevated inflammatory markers
- Psoas abscess — may be contiguous with SEA; hip flexion pain
- Meningitis — may coexist with SEA [2]
- Musculoskeletal back pain — the most common mimic; SEA is frequently misdiagnosed as benign back pain [1][3]
9. Past Medical History
- Prior episodes of SEA or vertebral osteomyelitis
- History of spinal surgery or instrumentation
- Diabetes mellitus, chronic kidney disease, liver disease
- HIV/AIDS, organ transplant, malignancy
- History of endocarditis or recurrent bacteremia
- Chronic indwelling catheters (PICC, dialysis catheter)
- Prior IVDU or alcohol use disorder
10. Physical Exam
- Vital signs: Fever present in only 24–62% of patients; tachycardia and hypotension suggest sepsis [2][12]
- Spine: Focal midline tenderness is a key finding — spine tenderness has a positive LR of 7.5 for SEA; its absence has a negative LR of 0.62. Percussion tenderness over the affected area [4]
- Neurologic exam (critical):
- Motor strength testing in all extremities
- Sensory exam including perianal/saddle sensation (saddle anesthesia PLR 22.6) [4]
- Deep tendon reflexes — hyporeflexia (cauda equina) vs. hyperreflexia (cord compression)
- Rectal tone assessment
- Gait evaluation
- Skin: Examine for injection sites, skin/soft tissue infections, surgical wounds
- 40% of patients present without neurological deficit [12]
11. Lab Studies
- ESR and CRP — most sensitive screening labs; typically markedly elevated (CRP >100 mg/L, ESR >60 mm/h). ESR >75 mm/h is associated with medical treatment failure [2][11]
- WBC — elevated in 60–80% but less sensitive and specific than ESR/CRP [2][7]
- Blood cultures — obtain before antibiotics; positive in 26–71% of cases. Concordance with surgical cultures ~60% [2][7]
- Procalcitonin — may be useful adjunct but not well studied specifically for SEA
- Basic metabolic panel, hepatic function, coagulation studies — for surgical planning and antibiotic dosing
- HIV testing if not previously known
- Lactate if sepsis is suspected
- Hemoglobin A1c in diabetic patients
12. Imaging
- First-line: MRI with gadolinium contrast — sensitivity 96%, specificity 93–94%. This is the diagnostic test of choice [2][14-15]
- Once SEA is diagnosed, image the entire spine — noncontiguous skip lesions found in up to 9% of patients [2]
- CT with IV contrast — inferior alternative when MRI is unavailable; sensitivity as low as 18% [2]
- PET-CT — alternative in patients who cannot undergo MRI, though inferior [2]
- CT myelography — invasive, rarely performed; risk of subarachnoid contamination [7]
- Repeat MRI in 2–3 weeks if initial MRI is unremarkable but clinical suspicion persists [7]
- DWI sequences can further aid in abscess characterization and distinguish from Modic type 1 changes [14]
13. Special Tests
- Image-guided needle aspiration/biopsy — for microbiologic diagnosis when blood cultures are negative and surgery is not imminent; target accessible contiguous sites (psoas abscess, paraspinal collection) over epidural fluid to avoid thecal puncture [2]
- Intraoperative cultures — 3–5 tissue/fluid samples for aerobic and anaerobic culture with Gram stain [2]
- Lumbar puncture should be avoided — risk of contaminating the subarachnoid space [8]
- Echocardiography — consider to evaluate for concurrent endocarditis, especially with S. aureus bacteremia [8]
- Predictive models for medical treatment failure: Age >65, diabetes, MRSA, neurologic deficit at presentation, CRP >115, WBC >12.5, positive blood cultures [2][13]
14. ECG
- ECG is not directly diagnostic for SEA
- Obtain ECG if sepsis is present (evaluate for tachyarrhythmias, ischemia)
- Relevant if concurrent endocarditis is suspected (conduction abnormalities, new heart block)
- Baseline ECG before initiating vancomycin (QTc monitoring if combined with other QT-prolonging agents)
15. Assessment
- SEA is a time-sensitive infectious disease emergency with a high rate of diagnostic delay — 71% of patients had potentially related visits in the 30 days prior to diagnosis [3]
- Staphylococcus aureus is the causative pathogen in >50% of cases, evenly split between MSSA and MRSA [2][8]
- Other pathogens: streptococci, aerobic gram-negative bacilli, anaerobes; rarely mycobacteria, fungi, Nocardia [9]
- Thoracic spine is most commonly affected in hematogenous cases; lumbar spine is most common overall (51% in one large series) [3][8]
- Severity stratification should incorporate neurologic status (ASIA scale), sepsis criteria, and predictors of medical treatment failure [2][13]
- Mortality: ~3–6% in-hospital, 6–13% at 90 days; overall mortality ~11% [2][12]
16. Treatment Plan
Initial stabilization:
- ABCs, IV access, hemodynamic resuscitation if septic
- Obtain blood cultures immediately
Antibiotics:
- Empiric: Vancomycin + ceftriaxone (or cefepime in IVDU, surgical-site infection, sepsis, or significant neurologic deficits) [2]
- In neurologically intact, non-septic patients without cord compression: consider withholding antibiotics until image-guided biopsy to optimize culture yield [2]
- Narrow therapy based on culture and susceptibility data; ID consultation essential [2]
- Duration: 6–8 weeks parenteral, with individualization based on response; oral step-down may be appropriate in selected patients [2]
Surgical management:
- Urgent surgery indicated for new or progressive neurologic deficits — neurologic recovery is most likely when surgery occurs within 48–72 hours of symptom onset [2]
- Laminectomy with decompression is the standard surgical approach; multilevel laminectomy or catheter-based irrigation for extensive abscesses [2]
- Paralysis >48 hours is a poor prognostic sign but does not preclude some recovery [8]
Nonoperative management:
- May be appropriate in carefully selected patients: neurologically intact, no cord compression, no sepsis [2]
- Failure rate ~28–42%, and delayed surgery has worse outcomes than early surgery [2][11][13]
- Predictors of failure: DM, MRSA, age >65, elevated CRP/ESR, bacteremia, anterior epidural involvement, leukocytosis [2][11][13]
17. Disposition
- All patients with confirmed SEA require hospital admission — there is no role for outpatient management at diagnosis [2]
- ICU admission for sepsis, hemodynamic instability, or rapidly progressive neurologic deficits
- Spine surgery and infectious disease consultation are mandatory for all patients [2]
- Transfer to a facility with spine surgery capability if not available locally; telemedicine ID consultation can bridge the gap [2]
- Patients managed nonoperatively require close neurologic monitoring — serial exams at minimum every few hours initially [2]
- Observation in a monitored setting is appropriate for patients being considered for nonoperative management
18. Follow Up / Return Precautions
- During hospitalization: Serial neurologic exams; monitor ESR/CRP trends; repeat MRI if clinical worsening or inflammatory markers not improving [2]
- Post-discharge: Follow-up with ID and spine surgery; complete antibiotic course (typically via OPAT); monitor for PICC-line complications
- End-of-therapy evaluation: Neurologic exam, ESR/CRP compared to baseline; end-of-therapy MRI recommended for nonoperatively treated patients, those with MRSA, or those without abscess drainage [2]
- Return precautions (counsel patients explicitly):
- Any new or worsening weakness, numbness, or tingling
- New bowel or bladder dysfunction
- Worsening or new back/neck pain
- Fever or rigors
- Symptoms of line infection (redness, swelling, drainage at PICC site)
- Expected recovery: Most survivors are cured; recurrence is uncommon. Neurologic outcomes are best predicted by neurologic status at the time of treatment initiation. Meta-analysis shows good neurologic outcome in 86% with early surgery vs. 69% with nonoperative treatment [2]
References
1. High Risk and Low Prevalence Diseases: Spinal Epidural Abscess. — Long B, Carlson J, Montrief T, Koyfman A. The American Journal of Emergency Medicine. 2022.
2. High Risk and Low Prevalence Diseases: Spinal Epidural Abscess. — Long B, Carlson J, Montrief T, Koyfman A. The American Journal of Emergency Medicine. 2022.
3. High Risk and Low Prevalence Diseases: Spinal Epidural Abscess. — Long B, Carlson J, Montrief T, Koyfman A. The American Journal of Emergency Medicine. 2022.
4. Spinal Epidural Abscess. — Tande AJ, Currier BL, Osmon DR. The New England Journal of Medicine. 2026.
5. Spinal Epidural Abscess. — Tande AJ, Currier BL, Osmon DR. The New England Journal of Medicine. 2026.
6. Diagnostic Delays Are Common, and Classic Presentations Are Rare in Spinal Epidural Abscess. — Durant EJ, Copos S, Folck BF, et al. The Western Journal of Emergency Medicine. 2025.
7. Diagnostic Delays Are Common, and Classic Presentations Are Rare in Spinal Epidural Abscess. — Durant EJ, Copos S, Folck BF, et al. The Western Journal of Emergency Medicine. 2025.
8. Clinical Evaluation for Spinal Epidural Abscess in Patients With Staphylococcus Aureus Bacteraemia: A Diagnostic Accuracy Study. — Obeda MJ, Dalai AS, Monti EB, et al. Infectious Diseases. 2026.
9. Clinical Evaluation for Spinal Epidural Abscess in Patients With Staphylococcus Aureus Bacteraemia: A Diagnostic Accuracy Study. — Obeda MJ, Dalai AS, Monti EB, et al. Infectious Diseases. 2026.
10. Epidural Abscesses of the CNS. — Pradilla G, Ardila GP, Hsu W, Rigamonti D. The Lancet. Neurology. 2009.
11. Epidural Abscesses of the CNS. — Pradilla G, Ardila GP, Hsu W, Rigamonti D. The Lancet. Neurology. 2009.
12. Diagnosis and Treatment of Low Back Pain (LBP) (2022). — Maj Danielle Anderson DPT DSc OCS FAAOMPT, Thiru M. Annaswamy MD MA, LTC Adam J. Bevevino MD, et al Department of Veterans Affairs. 2022.
13. Diagnosis and Treatment of Low Back Pain (LBP) (2022). — Maj Danielle Anderson DPT DSc OCS FAAOMPT, Thiru M. Annaswamy MD MA, LTC Adam J. Bevevino MD, et al Department of Veterans Affairs. 2022.
14. Spinal Epidural Abscess: A Review with Special Emphasis on Earlier Diagnosis. — Bond A, Manian FA. BioMed Research International. 2016.
15. Spinal Epidural Abscess: A Review with Special Emphasis on Earlier Diagnosis. — Bond A, Manian FA. BioMed Research International. 2016.
16. Acute Spinal Cord Compression. — Ropper AE, Ropper AH. The New England Journal of Medicine. 2017.
17. Acute Spinal Cord Compression. — Ropper AE, Ropper AH. The New England Journal of Medicine. 2017.
18. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.
19. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.
20. ASRA Pain Medicine Consensus Practice Infection Control Guidelines for Regional Anesthesia and Pain Medicine. — Provenzano DA, Hanes M, Hunt C, et al. Regional Anesthesia and Pain Medicine. 2025.
21. ASRA Pain Medicine Consensus Practice Infection Control Guidelines for Regional Anesthesia and Pain Medicine. — Provenzano DA, Hanes M, Hunt C, et al. Regional Anesthesia and Pain Medicine. 2025.
22. Outcomes and Factors Associated With Medical Treatment Failure in Patients With Spinal Epidural Abscess: A 14-Year Experience. — García de Santos M, Calderón-Parra J, Gutiérrez-Villanueva A, et al. PloS One. 2025.
23. Outcomes and Factors Associated With Medical Treatment Failure in Patients With Spinal Epidural Abscess: A 14-Year Experience. — García de Santos M, Calderón-Parra J, Gutiérrez-Villanueva A, et al. PloS One. 2025.
24. Clinical Characteristics of Patients With Spinal Epidural Abscess: A Systematic Review and Meta-Analysis. — Budiman L, Abetz JW, Mitra B. Emergency Medicine Australasia : EMA. 2026.
25. Clinical Characteristics of Patients With Spinal Epidural Abscess: A Systematic Review and Meta-Analysis. — Budiman L, Abetz JW, Mitra B. Emergency Medicine Australasia : EMA. 2026.
26. Spinal Epidural Abscesses: Risk Factors, Medical Versus Surgical Management, a Retrospective Review of 128 Cases. — Patel AR, Alton TB, Bransford RJ, et al. The Spine Journal : Official Journal of the North American Spine Society. 2014.
27. Spinal Epidural Abscesses: Risk Factors, Medical Versus Surgical Management, a Retrospective Review of 128 Cases. — Patel AR, Alton TB, Bransford RJ, et al. The Spine Journal : Official Journal of the North American Spine Society. 2014.
28. ACR Appropriateness Criteria® Cervical Pain or Cervical Radiculopathy: 2024 Update. — Eldaya RW, Parsons MS, Hutchins TA, et al. Journal of the American College of Radiology : JACR. 2025.
29. ACR Appropriateness Criteria® Cervical Pain or Cervical Radiculopathy: 2024 Update. — Eldaya RW, Parsons MS, Hutchins TA, et al. Journal of the American College of Radiology : JACR. 2025.
30. ACR Appropriateness Criteria® Suspected Spine Infection. — Expert Panel on Neurological Imaging, Ortiz AO, Levitt A, et al. Journal of the American College of Radiology : JACR. 2021.
31. ACR Appropriateness Criteria® Suspected Spine Infection. — Expert Panel on Neurological Imaging, Ortiz AO, Levitt A, et al. Journal of the American College of Radiology : JACR. 2021.